- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/425 - Thiazoles
Patent holdings for IPC class A61K 31/425
Total number of patents in this class: 972
10-year publication summary
|
40
|
37
|
50
|
41
|
30
|
31
|
19
|
38
|
53
|
31
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Sharp & Dohme Corp. | 2184 |
16 |
| Bristol-myers Squibb Company | 4764 |
11 |
| Janssen Pharmaceutica N.V. | 3160 |
11 |
| Abbvie Inc. | 1799 |
11 |
| PanOptica, Inc. | 13 |
10 |
| F. Hoffmann-La Roche AG | 7800 |
9 |
| The Regents of the University of California | 20842 |
9 |
| Allergan, Inc. | 2155 |
9 |
| Romark Laboratories L.C. | 43 |
8 |
| Glaxosmithkline LLC | 526 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2669 |
7 |
| Disarm Therapeutics, Inc. | 56 |
7 |
| Nutrition & Biosciences USA 2, LLC | 67 |
7 |
| Areteia Therapeutics, Inc. | 51 |
7 |
| Vertex Pharmaceuticals Incorporated | 1575 |
6 |
| Eli Lilly and Company | 4114 |
6 |
| Merck Sharp & Dohme LLC | 3738 |
6 |
| Novartis AG | 10175 |
5 |
| Duke University | 3186 |
5 |
| Centaurus Biopharma Co., Ltd. | 76 |
5 |
| Other owners | 810 |